7th Annual Immuno-Oncology Summit 2019
Date: August 5 - 9, 2019
Venue: Westin Boston Waterfront, Boston, MA USA
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Update History
2019/07/09
Sponsor updated
2019/06/20
Sponsor updated
2019/05/17
Agenda,Sponsor updated
2019/04/10
Agenda updated
2019/04/09
Agenda,Sponsor updated
2019/03/28
Sponsor updated
Download
Brochure (PDF)
Download Brochure(PDF)

Industry’s Leading Immuno-Oncology Annual Meeting

Join over 675 IO thought leaders at industry's leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network with decision makers and build lasting collaborations with an international mix of delegates, and gain actionable solutions to drive your organization's next-generation immunotherapy programs.


Why attend CHI’s Immuno-Oncology Summit?


NETWORK
with 675+ IO thought leaders from 28 countries and 400 companies

LEARN
the latest developments in immuno-oncology from 175+ scientific presentations and 40+ posters

CUSTOMIZE
your comprehensive 5-day program by selecting from 12-tracks, 2 training seminars, partnering forum and 4 courses

CONNECT
at the industry’s leading Immuno-Oncology meeting, with 72% of delegates from biotech and pharma

COLLABORATE
and build lasting business relationships with IO decision-makers: 46% of delegates are executive/director level

INNOVATE
your projects with technology solutions from 40+ exhibitors and 20+ technical presentations

BRAINSTORM
actionable solutions at the expertly-facilitated roundtable discussions

FOCUS
on your agenda by track hopping between concurrent tracks

SHOWCASE
your research by presenting a scientific poster

Emerging Company Showcase

The Immuno-Oncology Investing and Partnering Forum will play host to an Emerging Company Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.